Table 2.
Recurrence/progression events | CT alone, N (%) | CT+RT, N (%) | CT+S, N (%) | P |
---|---|---|---|---|
Locoregional only | 21 (38.9) | 30 (27.8) | 34 (25.2) | 0.3 |
Distant only | 19 (35.2) | 54 (50) | 66 (48.9) | |
Both | 14 (25.9) | 24 (22.2) | 35 (25.9) |
CT+RT, chemotherapy plus radiotherapy; CT+S, chemotherapy plus surgery; LS-SCEC, limited-stage small cell esophageal carcinoma.